{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:52:58Z","timestamp":1790949178689,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1053\/j.akdh.2024.04.007","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T16:03:10Z","timestamp":1720800190000},"page":"206-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Anti\u2013Glomerular Basement Membrane Disease: Recent Updates"],"prefix":"10.1053","volume":"31","author":[{"given":"Joyita","family":"Bharati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-0524","authenticated-orcid":false,"given":"Kenar D.","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1532-2390","authenticated-orcid":false,"given":"Louise","family":"Oni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.akdh.2024.04.007_bib1","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.01380217","article-title":"Anti-glomerular basement membrane disease","volume":"12","author":"McAdoo","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.007_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.2012.375","article-title":"Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease","volume":"83","author":"Tang","year":"2013","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.007_bib3","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","article-title":"Rapidly progressive crescentic glomerulonephritis","volume":"63","author":"Jennette","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.akdh.2024.04.007_bib4","article-title":"An uncommon presentation of a rare disease: a case of anti-glomerular basement membrane disease without renal involvement","volume":"31","author":"Polman","year":"2020","journal-title":"Respir Med Case Rep"},{"issue":"8","key":"10.1053\/j.akdh.2024.04.007_bib5","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00467-021-05333-z","article-title":"Anti-glomerular basement membrane disease in children: a brief overview","volume":"37","author":"Dowsett","year":"2022","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2024.04.007_bib6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2215\/CJN.13591215","article-title":"Spatial and Temporal clustering of anti-glomerular basement membrane disease","volume":"11","author":"Canney","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1 Suppl 1","key":"10.1053\/j.akdh.2024.04.007_bib7","article-title":"US renal data system 2010 Annual data report","volume":"57","author":"Collins","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.007_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.kint.2020.06.009","article-title":"Anti\u2013glomerular basement membrane disease during the COVID-19 pandemic","volume":"98","author":"Prendecki","year":"2020","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.007_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ajim.4700210204","article-title":"The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture\u2019s syndrome)","volume":"21","author":"Bombassei","year":"1992","journal-title":"Am J Ind Med"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.007_bib10","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/ndt\/gfn761","article-title":"Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease","volume":"24","author":"Yang","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.akdh.2024.04.007_bib11","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1681\/ASN.2020101431","article-title":"Laminin-521 is a novel target of autoantibodies associated with lung hemorrhage in anti-GBM disease","volume":"32","author":"Shen","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.007_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ki.1990.195","article-title":"Entactin: a possible auto-antigen in the pathogenesis of non-Goodpasture anti-GBM nephritis","volume":"38","author":"Saxena","year":"1990","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.akdh.2024.04.007_bib13","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1681\/ASN.2018050519","article-title":"Inhibitory anti-peroxidasin antibodies in pulmonary-renal syndromes","volume":"29","author":"McCall","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2024.04.007_bib14","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1681\/ASN.2018090946","article-title":"Peroxidasin-a novel autoantigen in anti-GBM disease?","volume":"29","author":"McAdoo","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.007_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clim.2007.05.001","article-title":"Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease","volume":"124","author":"Yang","year":"2007","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1053\/j.akdh.2024.04.007_bib16","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1681\/ASN.2004100823","article-title":"Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture\u2019s antigen","volume":"16","author":"Bolton","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.007_bib17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI111328","article-title":"New avian model of experimental glomerulonephritis consistent with mediation by cellular immunity. Nonhumorally mediated glomerulonephritis in chickens","volume":"73","author":"Bolton","year":"1984","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.007_bib18","doi-asserted-by":"crossref","first-page":"F572","DOI":"10.1152\/ajprenal.00558.2018","article-title":"Role of regulatory T cells in experimental autoimmune glomerulonephritis","volume":"316","author":"Klinge","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8608","key":"10.1053\/j.akdh.2024.04.007_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0140-6736(88)90413-8","article-title":"Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis","volume":"2","author":"Neale","year":"1988","journal-title":"Lancet"},{"issue":"11","key":"10.1053\/j.akdh.2024.04.007_bib20","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/ndt\/gfy327","article-title":"Anti-glomerular basement membrane disease: an update on subgroups, pathogenesis and therapies","volume":"34","author":"Segelmark","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.007_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1681\/ASN.2022050581","article-title":"Risk Stratification to predict renal survival in anti-glomerular basement membrane disease","volume":"34","author":"Floyd","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.007_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.04290417","article-title":"Predicting outcome in patients with anti-GBM glomerulonephritis","volume":"13","author":"van Daalen","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.007_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/md.0b013e318067da56","article-title":"Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases","volume":"86","author":"Lazor","year":"2007","journal-title":"Medicine"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.007_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0208-2022","article-title":"Pulmonary renal syndrome: a clinical review","volume":"18","author":"Boyle","year":"2022","journal-title":"Breathe"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.007_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1053\/ajkd.1998.v31.pm9469509","article-title":"An 18-year-old man with Goodpasture\u2019s syndrome and ANCA-negative central nervous system vasculitis","volume":"31","author":"Rydel","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.007_bib26","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1053\/ajkd.2002.33385","article-title":"Goodpasture\u2019s disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques","volume":"39","author":"Salama","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.akdh.2024.04.007_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.915754","article-title":"Serodiagnosis of anti-glomerular basement membrane disease using a newly developed chemiluminescence Immunoassay","volume":"9","author":"K\u00fchnl","year":"2022","journal-title":"Front Med"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.007_bib28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ndt\/gfu399","article-title":"Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort","volume":"30","author":"Alchi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.007_bib29","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.kint.2018.07.020","article-title":"Development and validation of a renal risk score in ANCA-associated glomerulonephritis","volume":"94","author":"Brix","year":"2018","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.007_bib30","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ekir.2023.03.010","article-title":"Atypical anti-glomerular basement membrane disease","volume":"8","author":"Bharati","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"5 Pt 1","key":"10.1053\/j.akdh.2024.04.007_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-89-5-635","article-title":"Goodpasture\u2019s syndrome: diagnosis by transbronchial lung biopsy","volume":"89","author":"Abboud","year":"1978","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.007_bib32","first-page":"869","article-title":"Immunofluorescence of transbronchial biopsies in Goodpasture\u2019s syndrome","volume":"121","author":"Beechler","year":"1980","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"10.1053\/j.akdh.2024.04.007_bib33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/thorax.55.6.502","article-title":"Small vessel vasculitis of the lung","volume":"55","author":"Schwarz","year":"2000","journal-title":"Thorax"},{"issue":"11","key":"10.1053\/j.akdh.2024.04.007_bib34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","article-title":"Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression","volume":"134","author":"Levy","year":"2001","journal-title":"Ann Intern Med"},{"issue":"4S","key":"10.1053\/j.akdh.2024.04.007_bib35","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.007_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00005792-198507000-00003","article-title":"Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors","volume":"64","author":"Johnson","year":"1985","journal-title":"Medicine"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.007_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MD.0b013e31822f6f68","article-title":"Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study","volume":"90","author":"Cui","year":"2011","journal-title":"Medicine"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.007_bib38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ndt\/gfx057","article-title":"Diagnostic and management challenges in Goodpasture\u2019s (anti-glomerular basement membrane) disease","volume":"33","author":"Henderson","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.007_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12882-018-1038-7","article-title":"Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease","volume":"19","author":"Heitz","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.akdh.2024.04.007_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2015.04.003","article-title":"Rituximab in anti-GBM disease: a retrospective study of 8 patients","volume":"60","author":"Touzot","year":"2015","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.007_bib41","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/0886022X.2022.2097405","article-title":"Rituximab for the treatment of refractory anti-glomerular basement membrane disease","volume":"44","author":"Yang","year":"2022","journal-title":"Ren Fail"},{"issue":"7","key":"10.1053\/j.akdh.2024.04.007_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103568","article-title":"Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption","volume":"9","author":"Biesenbach","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1053\/j.akdh.2024.04.007_bib43","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1111\/j.1600-6143.2006.01502.x","article-title":"Recurrent glomerulonephritis after kidney transplantation","volume":"6","author":"Choy","year":"2006","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.007_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14179","article-title":"Long-term outcomes in kidney transplant recipients with end-stage kidney disease due to anti-glomerular basement membrane disease","volume":"35","author":"Singh","year":"2021","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.007_bib45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1053\/ajkd.2002.31997","article-title":"Renal transplant in patients with Alport\u2019s syndrome","volume":"39","author":"Byrne","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.007_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/1744-9987.13718","article-title":"Anti-glomerular basement membrane disease (Goodpasture disease): from pathogenesis to plasma exchange to IdeS","volume":"26","author":"Shin","year":"2022","journal-title":"Ther Apher Dial"},{"issue":"8","key":"10.1053\/j.akdh.2024.04.007_bib47","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/ndt\/gfq115","article-title":"Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes","volume":"25","author":"Yang","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.007_bib48","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.kint.2019.06.019","article-title":"The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane disease","volume":"96","author":"Soveri","year":"2019","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.007_bib49","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1681\/ASN.2021111460","article-title":"Endopeptidase cleavage of anti-glomerular basement membrane antibodies in\u00a0vivo in severe kidney disease: an Open-Label phase 2a study","volume":"33","author":"Uhlin","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.007_bib50","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1523-1755.2003.00241.x","article-title":"Anti-glomerular basement membrane disease","volume":"64","author":"Pusey","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.007_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2022.07.006","article-title":"Autoimmunity in anti-glomerular basement membrane disease: a review of mechanisms and Prospects for Immunotherapy","volume":"81","author":"Kuang","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.007_bib52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10157-008-0051-8","article-title":"Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan","volume":"12","author":"Hirayama","year":"2008","journal-title":"Clin Exp Nephrol"},{"key":"10.1053\/j.akdh.2024.04.007_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.889185","article-title":"Anti-glomerular basement membrane glomerulonephritis: a study in real Life","volume":"9","author":"S\u00e1nchez-Agesta","year":"2022","journal-title":"Front Med"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.007_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.007_bib55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1053\/j.akdh.2024.04.007_bib56","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.kint.2016.02.001","article-title":"The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis","volume":"89","author":"Nasr","year":"2016","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.akdh.2024.04.007_bib57","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMc0800484","article-title":"Anti-glomerular basement membrane disease after alemtuzumab","volume":"359","author":"Clatworthy","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.007_bib58","first-page":"124","article-title":"Anti-glomerular basement membrane-antibody disease in a patient treated with adalimumab for rheumatoid arthritis","volume":"9","author":"Heron","year":"2020","journal-title":"Life Sci Adv Exp Clin Endocrinol"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.007_bib59","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000518984","article-title":"Etanercept-induced anti-glomerular basement membrane disease","volume":"11","author":"Al-Chalabi","year":"2021","journal-title":"Case Rep Nephrol Dial"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.007_bib60","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/ndt\/16.3.518","article-title":"Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha","volume":"16","author":"Karkar","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.007_bib61","first-page":"135","article-title":"Anti-GBM disease following CTLA4 blockade in a patient with metastatic melanoma","volume":"3","author":"Sammartino","year":"2009","journal-title":"NDT Plus"},{"key":"10.1053\/j.akdh.2024.04.007_bib62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2018.05.015","article-title":"Goodpasture\u2019s disease in a patient with advanced lung cancer treated with nivolumab: an autopsy case report","volume":"122","author":"Takahashi","year":"2018","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1053\/j.akdh.2024.04.007_bib63","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ekir.2022.08.020","article-title":"Concomitant anti-GBM glomerulonephritis and acute interstitial nephritis following Programmed Death Receptor-1 blockade with nivolumab","volume":"7","author":"Tani","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.007_bib64","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13256-021-02766-w","article-title":"Atypical anti-glomerular basement membrane glomerulonephritis in a patient with metastatic melanoma treated with mitogen-activated protein kinase and immune checkpoint inhibitors: a case report","volume":"15","author":"Kyriazis","year":"2021","journal-title":"J Med Case Rep"},{"issue":"2","key":"10.1053\/j.akdh.2024.04.007_bib65","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.kint.2021.06.006","article-title":"Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination","volume":"100","author":"Sacker","year":"2021","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.akdh.2024.04.007_bib66","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.ekir.2021.09.008","article-title":"COVID-19 vaccination and glomerulonephritis","volume":"6","author":"Klomjit","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.akdh.2024.04.007_bib67","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000525737","article-title":"Anti-GBM disease after Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccination: a report of two cases","volume":"12","author":"Coorey","year":"2022","journal-title":"Case Rep Nephrol Dial"},{"issue":"8","key":"10.1053\/j.akdh.2024.04.007_bib68","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ekir.2022.04.089","article-title":"Atypical Antiglomerular basement membrane nephritis following immune checkpoint inhibitor","volume":"7","author":"Javaugue","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.akdh.2024.04.007_bib69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2016.05.015","article-title":"Outcomes of patients with Goodpasture syndrome: a nationwide cohort-based study from\u00a0the French Society of Hemapheresis","volume":"73","author":"Huart","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1053\/j.akdh.2024.04.007_bib70","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3389\/fimmu.2019.01665","article-title":"Prognostic factors in anti-glomerular basement membrane disease: a multicenter study of 119 patients","volume":"10","author":"Marques","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1053\/j.akdh.2024.04.007_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/0886022X.2020.1854301","article-title":"Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease - a fifteen year single center experience","volume":"43","author":"Zahir","year":"2021","journal-title":"Ren Fail"},{"issue":"5","key":"10.1053\/j.akdh.2024.04.007_bib72","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000523713","article-title":"Predictors of kidney outcomes of anti-glomerular basement membrane disease in a large Chinese cohort","volume":"53","author":"Jia","year":"2022","journal-title":"Am J Nephrol"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924000818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924000818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T05:55:01Z","timestamp":1722146101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813924000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2949813924000818"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2024.04.007","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti\u2013Glomerular Basement Membrane Disease: Recent Updates","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2024.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}